Inventor profile of:

Annie Bouchard

City:

Stoke

Country:

Canada

Published Applications:

15

Last publication date:

2023-02-09

Top Assignees for applications by Annie Bouchard

The entities that hold a legal rights for patent applications filed by inventor Bouchard Annie:

Recent patent applications by Bouchard Annie

Annie Bouchard from Stoke, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-02-09
US20230042703A1
Chemistry; metallurgy

Cardioprotective Lipid and Method of Use

#2 | 2022-02-24
US20220056057A1
Chemistry; metallurgy

Cardiopathy-reducing phosphodiester lipids

#3 | 2021-07-01
US20210198294A1
Chemistry; metallurgy

Cardiopathy-reducing phosphodiester lipids

#4 | 2020-04-09
US20200108056A1
Human necessities

Liposomal Mitigation of Drug-Induced Inhibition of the Cardiac IKR Channel

#5 | 2019-12-26
US20190389888A1
Chemistry; metallurgy

Cardiopathy-reducing phosphodiester lipids

#6 | 2019-12-26
US20190388422A1
Human necessities

PROTECTIVE EFFECT OF DMPC, DMPG, DMPC/DMPG, LYSOPG AND LYSOPC AGAINST DRUGS THAT CAUSE CHANNELOPATHIES

#7 | 2019-10-24
US20190320975A1
Human necessities

Liposomal mitigation of drug-induced inhibition of the cardiac Ichannel

#8 | 2019-06-06
US20190167585A1
Human necessities

Protective Effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC Against Drugs that Cause Channelopathies

#9 | 2019-01-10
US20190008878A1
Human necessities

COMPOSITIONS AND METHOD FOR REDUCING CARDIOTOXICITY

#10 | 2018-03-01
US20180055770A1
Human necessities

Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies

#11 | 2017-11-02
US20170312366A1
Human necessities

Prevention of drug-induced atrio-ventricular block

#12 | 2017-05-04
US20170119802A1
Human necessities

Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel

#13 | 2017-02-09
US20170035887A1
Human necessities

Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies

#14 | 2015-12-03
US20150343063A1
Human necessities

Protective effect of DMPC, DMPG, DMPC/DMPG, EGPG, LysoPG and LysoPC against drugs that cause channelopathies

#15 | 2015-06-18
US20150164878A1
Human necessities

Liposomal mitigation of drug-induced inhibition of the cardiac Ichannel

InventorID:

1193114 ⎘